Terms: = Breast cancer AND P2RY8, RP11-261P4_4, 286530, ENSG00000182162, MGC50878, P2Y8, Q86VZ1 AND Prognosis
6351 results:
1. [The effect of ubiquitin ligase Cullin3 on the proliferation, migration and invasion of triple-negative breast cancer cells and exploration of its mechanism].
He ZX; Li J; Wang QF; Cheng Q; Ni SJ
Zhonghua Yi Xue Za Zhi; 2024 May; 104(20):1868-1878. PubMed ID: 38782756
[No Abstract] [Full Text] [Related]
2. [The pathological characteristics and prognostic analysis of medullary thyroid microcarcinoma].
Li DP; Zhang JM; Zhang YH; Hu LF; Gao Y; Wei SF; Zheng XQ
Zhonghua Yi Xue Za Zhi; 2024 May; 104(20):1825-1830. PubMed ID: 38782750
[No Abstract] [Full Text] [Related]
3. Lactylproteome analysis indicates histone H4K12 lactylation as a novel biomarker in triple-negative breast cancer.
Cui Z; Li Y; Lin Y; Zheng C; Luo L; Hu D; Chen Y; Xiao Z; Sun Y
Front Endocrinol (Lausanne); 2024; 15():1328679. PubMed ID: 38779451
[TBL] [Abstract] [Full Text] [Related]
4. Prophylactic central lymph node dissection in cN0 papillary thyroid cancer: a comparative study of via breast and transoral approach versus via breast approach alone.
Qiu R; Fu J
Front Endocrinol (Lausanne); 2024; 15():1356739. PubMed ID: 38774230
[TBL] [Abstract] [Full Text] [Related]
5. Retrospective analysis of estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor-2 (HER2), Ki67 changes and their clinical significance between primary breast cancer and metastatic tumors.
Qi G; Zhang X; Gai X; Yan X
PeerJ; 2024; 12():e17377. PubMed ID: 38766488
[TBL] [Abstract] [Full Text] [Related]
6. Enhancing pathological complete response prediction in breast cancer: the role of dynamic characterization of DCE-MRI and its association with tumor heterogeneity.
Zhang X; Teng X; Zhang J; Lai Q; Cai J
Breast Cancer Res; 2024 May; 26(1):77. PubMed ID: 38745321
[TBL] [Abstract] [Full Text] [Related]
7. DNA methylation regulator-based molecular subtyping and tumor microenvironment characterization in hepatocellular carcinoma.
Zhao J; Liu Z; Yang K; Shen S; Peng J
Front Immunol; 2024; 15():1333923. PubMed ID: 38736884
[TBL] [Abstract] [Full Text] [Related]
8. Transcript and protein signatures derived from shared molecular interactions across cancers are associated with mortality.
Zhao Y; Li X; Loscalzo J; Smelik M; Sysoev O; Wang Y; Mahmud AKMF; Mansour Aly D; Benson M
J Transl Med; 2024 May; 22(1):444. PubMed ID: 38734658
[TBL] [Abstract] [Full Text] [Related]
9. A β-Carboline Derivate PAD4 Inhibitor Reshapes Neutrophil Phenotype and Improves the Tumor Immune Microenvironment against Triple-Negative breast cancer.
Zhu D; Lu Y; Yan Z; Deng Q; Hu B; Wang Y; Wang W; Wang Y; Wang Y
J Med Chem; 2024 May; 67(10):7973-7994. PubMed ID: 38728549
[TBL] [Abstract] [Full Text] [Related]
10. Identification and validation of a prognostic anoikis-related gene signature in papillary thyroid carcinoma by integrated analysis of single-cell and bulk RNA-sequencing.
Zheng K; Zhang XX; Yu X; Yu B; Yang YF
Medicine (Baltimore); 2024 May; 103(19):e38144. PubMed ID: 38728457
[TBL] [Abstract] [Full Text] [Related]
11. E3 ubiquitin ligase BCA2 promotes breast cancer stemness by up-regulation of SOX9 by LPS.
Zheng M; Liu W; Zhang R; Jiang D; Shi Y; Wu Y; Ge F; Chen C
Int J Biol Sci; 2024; 20(7):2686-2697. PubMed ID: 38725852
[TBL] [Abstract] [Full Text] [Related]
12. Role of Magnetic Resonance Mammography in the Evaluation of Indeterminate breast Lesions.
Mishra E; Kaur N; Kaur R; Dalal U; Handa U; Anand GS
J Assoc Physicians India; 2023 Nov; 71(11):76-84. PubMed ID: 38720501
[No Abstract] [Full Text] [Related]
13. Preexisting Diabetes and breast cancer Treatment Among Low-Income Women.
Bekele BB; Lian M; Schmaltz C; Greever-Rice T; Shrestha P; Liu Y
JAMA Netw Open; 2024 May; 7(5):e249548. PubMed ID: 38717774
[TBL] [Abstract] [Full Text] [Related]
14. Time Kinetics and prognosis roles of calcitonin after surgery for medullary thyroid carcinoma.
Guo F; Fu G; Li F; Hua Y; Wang Z; Zheng X; Zhao J; Gao M
World J Surg Oncol; 2024 May; 22(1):121. PubMed ID: 38711029
[TBL] [Abstract] [Full Text] [Related]
15. Factors influencing TSH suppression efficacy in postoperative papillary thyroid carcinoma patients: a retrospective cohort study.
Zhang Q; Zhong ZZ; Wu T; He YQ
BMC Surg; 2024 May; 24(1):133. PubMed ID: 38702652
[TBL] [Abstract] [Full Text] [Related]
16. Additional prognostic value of polymorphisms within the 3'-untranslated region of programmed cell death pathway genes in early-stage breast cancer.
Chen H; Chen M; Zeng B; Tang L; Nie Q; Jin X; Guo W; Chen L; Lin Y; Wang C; Fu F
Front Immunol; 2024; 15():1284579. PubMed ID: 38690279
[TBL] [Abstract] [Full Text] [Related]
17. Loss of tumor-derived SMAD4 enhances primary tumor growth but not metastasis following BMP4 signalling.
Chi LH; Redfern AD; Roslan S; Street IP; Burrows AD; Anderson RL
Cell Commun Signal; 2024 Apr; 22(1):248. PubMed ID: 38689334
[TBL] [Abstract] [Full Text] [Related]
18. Germline biallelic BRCA2 pathogenic variants and medulloblastoma: an international cohort study.
Kastellan S; Kalb R; Sajjad B; McReynolds LJ; Giri N; Samuel D; Milde T; Elbracht M; Holzhauer S; Niewisch MR; Kratz CP
J Hematol Oncol; 2024 Apr; 17(1):26. PubMed ID: 38685107
[TBL] [Abstract] [Full Text] [Related]
19. Deubiquitination of CDC6 by OTUD6A promotes tumour progression and chemoresistance.
Cui J; Liu X; Shang Q; Sun S; Chen S; Dong J; Zhu Y; Liu L; Xia Y; Wang Y; Xiang L; Fan B; Zhan J; Zhou Y; Chen P; Zhao R; Liu X; Xing N; Wu D; Shi B; Zou Y
Mol Cancer; 2024 Apr; 23(1):86. PubMed ID: 38685067
[TBL] [Abstract] [Full Text] [Related]
20. Crosstalk of disulfidptosis-related subtypes identifying a prognostic signature to improve prognosis and immunotherapy responses of clear cell renal cell carcinoma patients.
Ren L; Liu J; Lin Q; He T; Huang G; Wang W; Zhan X; He Y; Huang B; Mao X
BMC Genomics; 2024 Apr; 25(1):413. PubMed ID: 38671348
[TBL] [Abstract] [Full Text] [Related]
[Next]
